Last updated: June 5, 2026

Back to directory

CLEW ICU medical AI product profile

FDA-cleared clinical surveillance platform that uses machine-learning models to surface adult ICU deterioration risk and workflow notifications.

Screenshot of the official CLEW ICU product page
Clinical operations and revenue cycle

Best fit

Hospitals evaluating predictive surveillance for high-acuity units where ICU teams can govern alert routing, escalation, and local performance monitoring.

Primary use case
AI-driven clinical surveillance and predictive alerts for adult ICU patient deterioration and hemodynamic instability
Audience
ICU, tele-ICU, rapid response, clinical operations, virtual nursing, and hospital patient-safety teams
Risk level
High
Pricing signal
Enterprise hospital and partner pricing; request current module, integration, support, and regulatory documentation.
Official sources
6 official sources

Compare within workflow: Clinical operations and revenue cycle · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating CLEW ICU as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat as high-risk medical-device software and match deployment to the FDA-cleared indication, adult critical-care setting, prediction outputs, labeling, and change-control boundaries for K233216.
PrivacyReview EHR, bedside-device, tele-ICU, and cloud data flows; BAA terms; PHI retention; access controls; audit logs; security posture; support access; and whether privacy materials are website-only or customer-contract specific.
EvidenceDo not rely on clearance alone; validate local performance, alert thresholds, sensitivity, PPV, low-risk labeling, false negatives, false positives, workflow response, and subgroup performance.
WorkflowBest governed by ICU, tele-ICU, rapid-response, biomedical, informatics, and patient-safety owners with defined escalation rules, override review, downtime plans, and post-deployment monitoring.

Where CLEW ICU fits

CLEW describes CLEW ICU as an AI-driven clinical surveillance platform for high-acuity care with FDA-cleared class II predictive models; FDA records list K233216 for the CLEWICU System as a medium-term adjunctive predictive cardiovascular indicator with a January 13, 2024 substantial-equivalence decision.

Not for: Standalone diagnosis, autonomous treatment decisions, non-ICU populations outside the cleared intended use, or deployment without local validation and clinician response protocols.

What to verify before using CLEW ICU

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products